Literature DB >> 31485071

Structural basis of nucleosome recognition and modification by MLL methyltransferases.

Han Xue1, Tonghui Yao1, Mi Cao2, Guanjun Zhu1, Yan Li3, Guiyong Yuan2, Yong Chen1, Ming Lei2, Jing Huang4.   

Abstract

Methyltransferases of the mixed-lineage leukaemia (MLL) family-which include MLL1, MLL2, MLL3, MLL4, SET1A and SET1B-implement methylation of histone H3 on lysine 4 (H3K4), and have critical and distinct roles in the regulation of transcription in haematopoiesis, adipogenesis and development1-6. The C-terminal catalytic SET (Su(var.)3-9, enhancer of zeste and trithorax) domains of MLL proteins are associated with a common set of regulatory factors (WDR5, RBBP5, ASH2L and DPY30) to achieve specific activities7-9. Current knowledge of the regulation of MLL activity is limited to the catalysis of histone H3 peptides, and how H3K4 methyl marks are deposited on nucleosomes is poorly understood. H3K4 methylation is stimulated by mono-ubiquitination of histone H2B on lysine 120 (H2BK120ub1), a prevalent histone H2B mark that disrupts chromatin compaction and favours open chromatin structures, but the underlying mechanism remains unknown10-12. Here we report cryo-electron microscopy structures of human MLL1 and MLL3 catalytic modules associated with nucleosome core particles that contain H2BK120ub1 or unmodified H2BK120. These structures demonstrate that the MLL1 and MLL3 complexes both make extensive contacts with the histone-fold and DNA regions of the nucleosome; this allows ease of access to the histone H3 tail, which is essential for the efficient methylation of H3K4. The H2B-conjugated ubiquitin binds directly to RBBP5, orienting the association between MLL1 or MLL3 and the nucleosome. The MLL1 and MLL3 complexes display different structural organizations at the interface between the WDR5, RBBP5 and MLL1 (or the corresponding MLL3) subunits, which accounts for the opposite roles of WDR5 in regulating the activity of the two enzymes. These findings transform our understanding of the structural basis for the regulation of MLL activity at the nucleosome level, and highlight the pivotal role of nucleosome regulation in histone-tail modification.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31485071     DOI: 10.1038/s41586-019-1528-1

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  47 in total

1.  Regulation of the Dot1 histone H3K79 methyltransferase by histone H4K16 acetylation.

Authors:  Marco Igor Valencia-Sánchez; Pablo De Ioannes; Miao Wang; David M Truong; Rachel Lee; Jean-Paul Armache; Jef D Boeke; Karim-Jean Armache
Journal:  Science       Date:  2021-01-22       Impact factor: 47.728

Review 2.  The complex activities of the SET1/MLL complex core subunits in development and disease.

Authors:  Hao Jiang
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2020-04-15       Impact factor: 4.490

Review 3.  Insights on the regulation of the MLL/SET1 family histone methyltransferases.

Authors:  Liang Sha; Alex Ayoub; Uhn-Soo Cho; Yali Dou
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2020-04-15       Impact factor: 4.490

4.  Navigating the structure of COMPASS.

Authors:  Karolin Luger; Jonathan W Markert
Journal:  Elife       Date:  2020-02-24       Impact factor: 8.140

5.  A Binary Arginine Methylation Switch on Histone H3 Arginine 2 Regulates Its Interaction with WDR5.

Authors:  Benjamin M Lorton; Rajesh K Harijan; Emmanuel S Burgos; Jeffrey B Bonanno; Steven C Almo; David Shechter
Journal:  Biochemistry       Date:  2020-03-31       Impact factor: 3.162

Review 6.  The Bre1/Rad6 machinery: writing the central histone ubiquitin mark on H2B and beyond.

Authors:  Zhi-Heng Deng; Hua-Song Ai; Cheng-Piao Lu; Jia-Bin Li
Journal:  Chromosome Res       Date:  2020-09-07       Impact factor: 5.239

7.  KMT2C is a potential biomarker of prognosis and chemotherapy sensitivity in breast cancer.

Authors:  Xinhua Liu; Rongfang Qiu; Min Xu; Miaomiao Meng; Siyu Zhao; Jiansong Ji; Yang Yang
Journal:  Breast Cancer Res Treat       Date:  2021-07-08       Impact factor: 4.872

8.  PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation.

Authors:  Shao-Ming Shen; Cheng Zhang; Meng-Kai Ge; Shuang-Shu Dong; Li Xia; Ping He; Na Zhang; Yan Ji; Shuo Yang; Yun Yu; Jun-Ke Zheng; Jian-Xiu Yu; Qiang Xia; Guo-Qiang Chen
Journal:  Nat Cell Biol       Date:  2019-11-04       Impact factor: 28.824

9.  Structural Basis of H2B Ubiquitination-Dependent H3K4 Methylation by COMPASS.

Authors:  Peter L Hsu; Hui Shi; Calvin Leonen; Jianming Kang; Champak Chatterjee; Ning Zheng
Journal:  Mol Cell       Date:  2019-11-13       Impact factor: 17.970

Review 10.  The language of chromatin modification in human cancers.

Authors:  Shuai Zhao; C David Allis; Gang Greg Wang
Journal:  Nat Rev Cancer       Date:  2021-05-17       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.